June 22, 2020 - The London School of Hygiene & Tropical Medicine (LSHTM) and ARCTEC have announced the launch of an early version of their Global Vector Hub (GVH), GVH-Beta. Read more
January 9, 2020 - Scientists and technicians working on arbovirus projects in Senegal and West Africa are meeting for a training workshop organized by the Mérieux Foundation and Institut Pasteur of Dakar from January 6-10, 2020. Read more
October 30, 2019 - The Global Birth Defects Description and Coding (GBDDC) app has just been released today. This first of its kind app provides images and definitions of major externally visible birth defects with ICD codes, in addition to ... Read more
October 28, 2019 - The Universidad del Valle hosted the annual ZikaPLAN meeting October 21-22, convening over 60 consortium members in Cali, Colombia. Read more
October 24, 2019 - The toolkit is based on guidelines developed by scientists funded by the EUHorizon2020 grant and the ZikaPLAN-supported IGOSZika project. Read more
Maria Lúcia Brito Ferreira et al. – The Lancet Neurology, October 01, 2020
Since 2015, the arthropod-borne viruses (arboviruses) Zika and chikungunya have spread across the Americas causing outbreaks, accompanied by increases in immune-mediated and infectious neurological disease. The spectrum of neurological manifestations linked to these viruses, and the importance of dual infection, are not known fully. In this article, the authors aimed to investigate whether neurological presentations differed according to the infecting arbovirus, and whether patients with dual infection had a different disease spectrum or severity.
Defining the spectrum of neurological diseases associated with Zika virus (ZIKV) infection, in both the central nervous system (CNS) and peripheral nervous system (PNS) of adults and children.
To protect pregnant women, novel, wash-in detergent formulations and long-lasting plastic technologies containing repellents for the treatment of clothing and other wearable repellent technologies are being developed using new microencapsulation techniques.
Identifying the major T-cell epitopes and cross reactive B-cell epitopes on ZIKV and assessing the role of flavivirus antibodies in protective and pathogenic immunity following ZIKV through antibody dependent enhancement (ADE).
ZikaPLAN has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 734584.